Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Pancreatic Endocrine Tumor Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Pancreatic Endocrine Tumor Drugmarket, defines the market attractiveness level of Pancreatic Endocrine Tumor Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Pancreatic Endocrine Tumor Drug industry, describes the types of Pancreatic Endocrine Tumor Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pancreatic Endocrine Tumor Drug market and the development prospects and opportunities of Pancreatic Endocrine Tumor Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pancreatic Endocrine Tumor Drug market in Chapter 13.
By Player:
Ipsen SA
Jiangsu Hengrui Medicine Co, Ltd
Novartis AG
OXiGENE, Inc
MediaPharma srl
By Type:
Buparlisib Hydrochloride
Dovitinib Lactate
Fosbretabulin Tromethamine
Lanreotide Acetate
MPHE-001B
Others
By End-User:
Clinic
Research Center
Hospital
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Pancreatic Endocrine Tumor Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Pancreatic Endocrine Tumor Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Pancreatic Endocrine Tumor Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Pancreatic Endocrine Tumor Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Pancreatic Endocrine Tumor Drug Market Analysis and Outlook to 2022
-
7.1 Global Pancreatic Endocrine Tumor Drug Consumption (2017-2022)
-
7.2 United States Pancreatic Endocrine Tumor Drug Consumption (2017-2022)
-
7.3 Europe Pancreatic Endocrine Tumor Drug Consumption (2017-2022)
-
7.4 China Pancreatic Endocrine Tumor Drug Consumption (2017-2022)
-
7.5 Japan Pancreatic Endocrine Tumor Drug Consumption (2017-2022)
-
7.6 India Pancreatic Endocrine Tumor Drug Consumption (2017-2022)
-
7.7 South Korea Pancreatic Endocrine Tumor Drug Consumption (2017-2022)
8 Region and Country-wise Pancreatic Endocrine Tumor Drug Market Analysis and Outlook to 2028
-
8.1 Global Pancreatic Endocrine Tumor Drug Consumption Forecast (2022-2028)
-
8.2 United States Pancreatic Endocrine Tumor Drug Consumption Forecast (2022-2028)
-
8.3 Europe Pancreatic Endocrine Tumor Drug Consumption Forecast (2022-2028)
-
8.4 China Pancreatic Endocrine Tumor Drug Consumption Forecast (2022-2028)
-
8.5 Japan Pancreatic Endocrine Tumor Drug Consumption Forecast (2022-2028)
-
8.6 India Pancreatic Endocrine Tumor Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Pancreatic Endocrine Tumor Drug Consumption Forecast (2022-2028)
9 Global Pancreatic Endocrine Tumor Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Pancreatic Endocrine Tumor Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Buparlisib Hydrochloride Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Dovitinib Lactate Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Fosbretabulin Tromethamine Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Lanreotide Acetate Consumption and Growth Rate (2017-2022)
-
9.1.5 Global MPHE-001B Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Pancreatic Endocrine Tumor Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Research Center Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Hospital Consumption and Growth Rate (2017-2022)
10 Global Pancreatic Endocrine Tumor Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Pancreatic Endocrine Tumor Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Buparlisib Hydrochloride Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Dovitinib Lactate Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Fosbretabulin Tromethamine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Lanreotide Acetate Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global MPHE-001B Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Pancreatic Endocrine Tumor Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Research Center Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
11 Global Pancreatic Endocrine Tumor Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Pancreatic Endocrine Tumor Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Pancreatic Endocrine Tumor Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Pancreatic Endocrine Tumor Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Pancreatic Endocrine Tumor Drug Market Competitive Analysis
-
14.1 Ipsen SA
-
14.1.1 Ipsen SA Company Details
-
14.1.2 Ipsen SA Pancreatic Endocrine Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Ipsen SA Pancreatic Endocrine Tumor Drug Product and Service
-
14.2 Jiangsu Hengrui Medicine Co, Ltd
-
14.2.1 Jiangsu Hengrui Medicine Co, Ltd Company Details
-
14.2.2 Jiangsu Hengrui Medicine Co, Ltd Pancreatic Endocrine Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Jiangsu Hengrui Medicine Co, Ltd Pancreatic Endocrine Tumor Drug Product and Service
-
14.3 Novartis AG
-
14.3.1 Novartis AG Company Details
-
14.3.2 Novartis AG Pancreatic Endocrine Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis AG Pancreatic Endocrine Tumor Drug Product and Service
-
14.4 OXiGENE, Inc
-
14.4.1 OXiGENE, Inc Company Details
-
14.4.2 OXiGENE, Inc Pancreatic Endocrine Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 OXiGENE, Inc Pancreatic Endocrine Tumor Drug Product and Service
-
14.5 MediaPharma srl
-
14.5.1 MediaPharma srl Company Details
-
14.5.2 MediaPharma srl Pancreatic Endocrine Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 MediaPharma srl Pancreatic Endocrine Tumor Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Pancreatic Endocrine Tumor Drug
-
Figure Pancreatic Endocrine Tumor Drug Picture
-
Table Global Pancreatic Endocrine Tumor Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pancreatic Endocrine Tumor Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pancreatic Endocrine Tumor Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Pancreatic Endocrine Tumor Drug Consumption by Country (2017-2022)
-
Figure United States Pancreatic Endocrine Tumor Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Pancreatic Endocrine Tumor Drug Consumption and Growth Rate (2017-2022)
-
Figure China Pancreatic Endocrine Tumor Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Pancreatic Endocrine Tumor Drug Consumption and Growth Rate (2017-2022)
-
Figure India Pancreatic Endocrine Tumor Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pancreatic Endocrine Tumor Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Pancreatic Endocrine Tumor Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Pancreatic Endocrine Tumor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pancreatic Endocrine Tumor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Pancreatic Endocrine Tumor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pancreatic Endocrine Tumor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pancreatic Endocrine Tumor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pancreatic Endocrine Tumor Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Buparlisib Hydrochloride Consumption and Growth Rate (2017-2022)
-
Figure Global Dovitinib Lactate Consumption and Growth Rate (2017-2022)
-
Figure Global Fosbretabulin Tromethamine Consumption and Growth Rate (2017-2022)
-
Figure Global Lanreotide Acetate Consumption and Growth Rate (2017-2022)
-
Figure Global MPHE-001B Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Research Center Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Buparlisib Hydrochloride Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dovitinib Lactate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fosbretabulin Tromethamine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lanreotide Acetate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global MPHE-001B Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Center Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Pancreatic Endocrine Tumor Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Pancreatic Endocrine Tumor Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Ipsen SA (Foundation Year, Company Profile and etc.)
-
Table Ipsen SA Pancreatic Endocrine Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ipsen SA Pancreatic Endocrine Tumor Drug Product and Service
-
Table Jiangsu Hengrui Medicine Co, Ltd (Foundation Year, Company Profile and etc.)
-
Table Jiangsu Hengrui Medicine Co, Ltd Pancreatic Endocrine Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jiangsu Hengrui Medicine Co, Ltd Pancreatic Endocrine Tumor Drug Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Pancreatic Endocrine Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Pancreatic Endocrine Tumor Drug Product and Service
-
Table OXiGENE, Inc (Foundation Year, Company Profile and etc.)
-
Table OXiGENE, Inc Pancreatic Endocrine Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table OXiGENE, Inc Pancreatic Endocrine Tumor Drug Product and Service
-
Table MediaPharma srl (Foundation Year, Company Profile and etc.)
-
Table MediaPharma srl Pancreatic Endocrine Tumor Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table MediaPharma srl Pancreatic Endocrine Tumor Drug Product and Service
-
